|
|||||||||||||||||||||||||||
| A-0902 | Alarin (rat) | C119H199N45O35 | 2820.17 | 909409-88-7 | H-Ala-Pro-Ala-His-Arg-Ser-Ser-Thr-Phe-Pro-Gln-Arg-Pro-Thr-Arg-Ala-Gly-Arg-Gln-Thr-Gln-Leu-Leu-Arg-Ser-OH |
| A-1001 | Type A Allatostatin I | C61H94N18O16 | 1335.53 | 123338-10-3 | H-Ala-Pro-Ser-Gly-Ala-Gln-Arg-Leu-Tyr-Gly-Phe-Gly-Leu-NH2 |
| A-1002 | Type A Allatostatin II | C49H74N14O13 | 1067.21 | 123338-11-4 | H-Gly-Asp-Gly-Arg-Leu-Tyr-Ala-Phe-Gly-Leu-NH2 |
| A-1003 | Type A Allatostatin III | C42H62N10O12 | 899.01 | 123338-12-5 | H-Gly-Gly-Ser-Leu-Tyr-Ser-Phe-Gly-Leu-NH2 |
| A-1004 | Type A Allatostatin IV | C45H68N12O12 | 969.11 | 123338-13-6 | H-Asp-Arg-Leu-Tyr-Ser-Phe-Gly-Leu-NH2 |
| A-1005 | Type B Allatostatin | C104H150N24O27 | 2168.48 | 134760-78-4 | H-Ala-Tyr-Ser-Tyr-Val-Ser-Glu-Tyr-Lys-Arg-Leu-Pro-Val-Tyr-Asn-Phe-Gly-Leu-NH2 |
| A-1101 | Alloferon 1 | C52H76N22O16 | 1265.31 | 347884-61-1 | H-His-Gly-Val-Ser-Gly-His-Gly-Gln-His-Gly-Val-His-Gly-OH |
| A-1102 | Alloferon 2 | C46H69N19O15 | 1128.17 | 347884-62-2 | H-Gly-Val-Ser-Gly-His-Gly-Gln-His-Gly-Val-His-Gly-OH |
| A-1201 | Amastatin · HCl | C21H38N4O8 · HCl | 511.02 | 100938-10-1 | [(2S,3R)-3-Amino-2-hydroxy-5-methylhexanoyl]-Val-Val-Asp-OH |
| A-1202 | Epiamastatin · HCl | C21H38N4O8 · HCl | 511.02 | 100992-59-4 | [(2R,3R)-3-Amino-2-hydroxy-5-methylhexanoyl]-Val-Val-Asp-OH · HCl |
